Video

How Novel Technology Improves Patients' Lives

Danny Sanchez, VP and general manager of population health services for Omnicell, discusses how technology is bringing pharmacists closer to their patients. This video was filmed at the 2019 ASHP Midyear Clinical Meeting & Exhibition in Las Vegas.

Danny Sanchez, VP and general manager, population health services for Omnicell, discusses how technology is bringing pharmacists closer to their patients. This video was filmed at the 2019 ASHP Midyear Clinical Meeting & Exhibition in Las Vegas.

Danny Sanchez: Technology as a whole can sometimes be a little bit scary. Certainly, when you’re dealing with [artificial intelligence] devices, and in-home voice devices, the thought of somebody listening to your speech at home or to your conversations can be intimidating. What we’ve done, is we’ve gone and partnered with the retail pharmacies, knowing that voice services is going to be the future. It is going to be the next cell phone, we know that. We see the adoption is huge. Year-to-year you’re seeing hundreds of millions of people adopting it, year-to-year. The technology itself has evolved over the last couple of years. So what we’ve done, partnering with Amazon, I think speaks a lot to the fact that you can use this technology to benefit people and help them stay on their medication regimens. You know, the solution that we have today with Amazon, will remind you at home when to take your medications. It gives you easier access to your pharmacy when refilling your medications. I think it’s a great example of how we can turn this solution around and say, you know, let’s maximize it so that people can get value from it from a health care perspective. And I think we’re at the tip of the iceberg with that.

Related Videos
Image Credit: © alenamozhjer - stock.adobe.com
pharmacogenetics testing, adverse drug events, personalized medicine, FDA collaboration, USP partnership, health equity, clinical decision support, laboratory challenges, study design, education, precision medicine, stakeholder perspectives, public comment, Texas Medical Center, DNA double helix
pharmacogenetics challenges, inter-organizational collaboration, dpyd genotype, NCCN guidelines, meta census platform, evidence submission, consensus statements, clinical implementation, pharmacotherapy improvement, collaborative research, pharmacist role, pharmacokinetics focus, clinical topics, genotype-guided therapy, critical thought
Image Credit: © Andrey Popov - stock.adobe.com
Image Credit: © peopleimages.com - stock.adobe.com
TRUST-I and TRUST-II Trials Show Promising Results for Taletrectinib in ROS1+ NSCLC
Image Credit: © Cavan - stock.adobe.com
Image Credit: © utah51 - stock.adobe.com
Image Credit: © Rawpixel.com - stock.adobe.com